| Product Information |
|
| Registration Number |
DR-XY35505
|
| Generic Name |
Clevudine
|
| Brand Name |
Revovir
|
| Dosage Strength |
30 mg
|
| Dosage Form |
Capsule
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antiviral [Nucleoside/Nucleotide
Transcriptase Inhibitor]
|
| Packaging |
HDPE bottle of 30 capsules with desiccant
|
| Manufacturer |
Bukwang Pharm. Co., Ltd.
|
| Country of Origin |
Korea
|
| Trader |
|
| Importer |
HI-Eisai Pharmaceutical, Inc.
|
| Distributor |
Zuellig Pharma Corporation
|
| Application Type |
Initial [from Monitored Release]
|
| Issuance Date |
30 May 2022
|
| Expiry Date |
07 March 2026
|